Advanced Oncotherapy (AVO) has warned that delivery of its next generation proton beam therapy LIGHT system with a 230MeV beam could be delayed until next year due to supply chain issues. The London listed company said the international shortage of semi-conductors and thermo-switches could swing delivery of the system into Q1 2022. Losses edged up to…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
 has warned that delivery of its next generation proton beam therapy LIGHT system with a 230MeV beam could be delayed until next year due to supply chain issues.){kind=link}